An investigation was announced for investors of LivaNova PLC (NASDAQ:LIVN) shares concerning potential securities laws violations by LivaNova PLC and certain of its directors and officers.
Investors who purchased shares of LivaNova PLC (NASDAQ:LIVN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on whether certain statements by LivaNova PLC regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
London based LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. LivaNova PLC reported that its Total Revenue rose from $291.56 million for the 52 weeks period that ended on April 24, 2015 to over $1.21 billion for the 12 months period that ended on December 31, 2016 and that its Net Income of $57.85 million declined to a Net loss of $62.79 million.
On March 31, 2017, LivaNova PLC announced the resignation of its Chief Financial Officer (“CFO”), Vivid Sehgal. Sehgal, who has been with LivaNova since the Company’s inception in October of 2015, is leaving to “pursue other opportunities” and will “continue as CFO … and support an orderly transition to his successor”.
Shares of LivaNova PLC (NASDAQ:LIVN) closed on April 13, 2017 at $50.71 per share.
Those who purchased NASDAQ:LIVN shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com